Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients

Clinical trial NCT03847311 · COMPLETED

Trial details

NCT number: NCT03847311
Sponsor: University of Arizona
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Chronic Pain Due to Malignancy (Finding)

Start date: 2021-05-03
Primary completion: 2023-10-09
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.